Why Manhattan Associates, Inc. (MANH) stock moved
Manhattan Associates, Inc. (MANH) shares rose 0.3% to $257.15 as of November 16, 2026, a slight gain from the prior close of $256.37. BestStocks flagged the session as a major change for MANH. The move is tied to company news. Below, we break down what changed for MANH, why it matters for investors, how the stock reacted, and the catalysts on the calendar.
Company News
Law firm Kahn Swick & Foti initiates investigation into MANH's officers and directors. Investigation signals potential governance concerns that could trigger shareholder litigation and regulatory scrutiny.
What it means for Manhattan Associates, Inc. investors
For Manhattan Associates, Inc. investors, the recent signals are mixed, leaving the near-term picture neutral / mixed. On the constructive side: Positive 0.3% session move; Positive price momentum. Weighing against that: Manhattan Associates, Inc. (MANH) moved -6.29% from $159.12 to $149.11 on 2026-07-22; New SEC filing — review for material disclosures. Wall Street's consensus price target sits at $260.00, implying +1.1% upside from $257.15. Over the past 90 days analysts logged 1 upgrade and 1 downgrade. BestStocks rates the overall signal quality weak (30/100). With earnings roughly 71 days out, the next report is the most likely near-term test of the move.
MANH price reaction
MANH last traded at $257.15, up $0.78 (+0.30%) from the previous close of $256.37. The session traded on 0.4× average volume (below avg), so participation was unremarkable.
Bullish and bearish analyst opinions on Manhattan Associates, Inc. (MANH)
The consensus analyst price target on Manhattan Associates, Inc. (MANH) is $260.00, 1.1% above the recent $257.15. Over the past 90 days analysts logged 1 upgrade, 9 maintains, and 1 downgrade. Here is how the bullish and bearish cases on MANH line up.
The bullish case
- Wall Street's consensus price target of $260.00 implies +1.1% upside from $257.15.
- The Street's most bullish target is $305.00 (+18.6%).
- 1 analyst upgrade in the past 90 days, most recently Morgan Stanley to Overweight (2026-10-12).
- Positive 0.3% session move.
- Positive price momentum.
The bearish case
- The most bearish analyst target is $210.00 (-18.3%).
- 1 analyst downgrade in the past 90 days, most recently DA Davidson to Neutral (2026-09-28).
- Manhattan Associates, Inc. (MANH) moved -6.29% from $159.12 to $149.11 on 2026-07-22.
Weighing both sides, BestStocks' composite read of recent signals is roughly balanced, as the bull-versus-bear meter above shows. This is an educational summary of the bull and bear case, not investment advice.
Analyst price targets and ratings are FMP consensus figures as of Nov 15, 2026; other aggregators may differ. High and low targets show the range of estimates, not forecasts.
Previous notable changes for MANH
In-depth MANH event analyses
Frequently asked questions about MANH
Why did Manhattan Associates, Inc. (MANH) stock move?
MANH rose 0.3% to $257.15. The move coincided with the context summarized above, though no single company-specific catalyst was independently confirmed.
How much did MANH stock rise?
MANH gained 0.30% ($0.78) versus the prior close of $256.37, last trading at $257.15 on 0.4× average volume.
When is Manhattan Associates, Inc.'s next earnings date?
MANH's next earnings report is estimated for 2027-01-26 — about 71 days away.
What is the analyst price target for MANH?
The consensus analyst price target for MANH is $260.00, about 1.1% above the current $257.15. Over the past 90 days, analysts recorded 1 upgrade, 9 maintains, and 1 downgrade.
How BestStocks tracks MANH
This page is generated automatically by BestStocks' change-detection system after company news was detected and verified against independent data sources. It draws on 20 tracked change events for MANH, cross-checked against the data sources listed below. Price, volume, and market-capitalization figures are the live intraday quote as of November 16, 2026 and refresh as new information is detected; for companies with multiple share classes, market-cap figures can differ by data source. Analyst price targets and ratings are FMP consensus. This is an educational summary of what changed and why — not personalized investment advice.

